Intergrin has raised financing provided by Kartesia
Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.
Intergrin is a Dutch healthcare provider that operates clinics focused on specialized mental healthcare through its two brands, Het Rughuis and PHI. The company is headquartered in Geleen and currently has twelve treatment locations across the south of the country. Het Rughuis provides psychosomatic treatments to individuals with spine-related pain disorders through a combination of expert cognitive behavioral therapy, lifestyle-as-a-medicine therapy, vitality and physical therapy. PHI offers specialized psychosomatic mental healthcare to those suffering from anxiety, depression, somatoform disorder and serious unexplained physical complaints. Intergrin has unrivalled high success rates and delivers sustainable results, thereby significantly improving the quality of life of patients while also lowering the medical costs to society.
The loan was provided by Kartesia, a pan-European, independent and privately owned specialist provider of financing solutions, focused on offering customized resources across the capital structure to leading mid-market companies from a wide range of industries, with the view to accelerate their pace of growth.
Oaklins’ debt advisory team in the Netherlands advised Intergrin in this transaction and assisted in establishing a financing package aligned with the current business profile and future growth ambitions. This transaction emphasizes Oaklins’ strong track record in the healthcare clinics sector, which previously included deals such as Tandarts Today, Curious Kids and Dutch Dental Group.
Ron Joosten and Marc Kuijpers
Founders, Intergrin
Talk to the deal team
Niels Vermuë
Oaklins Netherlands
Related deals
Rare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreGSP Group has secured an upsized growth refinancing package from HSBC
The GSP Group has refinanced its growth facilities through an upsized financing package provided by HSBC.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more